作者: SJ Vaidya , Geoffrey S Payne , Martin O Leach , CR Pinkerton , None
DOI: 10.1016/S0959-8049(02)00728-1
关键词:
摘要: This brief review considers to what extent Magnetic Resonance Spectroscopy (MRS) can play a role in monitoring early tumour response with examples of preclinical studies and selected clinical tumours children young adults. An non-invasive indicator therapy would provide useful information regarding the effectiveness therapy. might be relevant prognostic factor new patients phase II could facilitate recommendations at an stage as whether continue treatment. suggests that several markers ratios are emerging potential markers, but larger prospective needed before translating this into practice.